VEGFB and hepatocellular carcinoma: In the present study, histidine supplementation in HCC cells reduced the expression of tumor markers related to glycolysis (GLUT1 and HK2), inflammation (pSTAT3), angiogenesis (VEGFB and VEGFC), stem cells (CD133), metastasis (Snail/slug), and cell migration.